Selected research
Industry Research
Metformin Hydrochloride Industry Research Report 2026
Market perspective
The global Metformin Hydrochloride market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Metformin Hydrochloride is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Metformin Hydrochloride is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Metformin Hydrochloride is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Metformin Hydrochloride include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Metformin Hydrochloride market in revenue (US$ million) and, where applicable, sales volume (K Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/K Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Metformin Hydrochloride.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Metformin Hydrochloride Market by Company
Aarti Drugs
Farmhispania Group
CR Double-Crane
Wanbury
Harman Finochem
Exemed Pharmaceuticals
USV
Shijiazhuang Polee Pharmaceutical
Keyuan Pharmaceutical
Shouguang Fukang Pharmaceutical
Vistin Pharma
Metformin Hydrochloride Segment by Type
Metformin HCL
Metformin DC
Others
Metformin Hydrochloride Segment by Application
Metformin Hydrochloride Tablets
Metformin Hydrochloride Extended-Release Tablets
Others
Metformin Hydrochloride Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metformin Hydrochloride market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Metformin Hydrochloride and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metformin Hydrochloride.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Metformin Hydrochloride manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Metformin Hydrochloride by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Metformin Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Metformin HCL
- Metformin DC
- Others
Applications
- Metformin Hydrochloride Tablets
- Metformin Hydrochloride Extended-Release Tablets
- Others
Companies covered
- Aarti Drugs
- Farmhispania Group
- CR Double-Crane
- Wanbury
- Harman Finochem
- Exemed Pharmaceuticals
- USV
- Shijiazhuang Polee Pharmaceutical
- Keyuan Pharmaceutical
- Shouguang Fukang Pharmaceutical
- Vistin Pharma
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Metformin Hydrochloride by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Metformin HCL
- 2.2.3 Metformin DC
- 2.2.4 Others
- 2.3 Metformin Hydrochloride by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Metformin Hydrochloride Tablets
- 2.3.3 Metformin Hydrochloride Extended-Release Tablets
- 2.3.4 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Metformin Hydrochloride Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Metformin Hydrochloride Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Metformin Hydrochloride Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Metformin Hydrochloride Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Metformin Hydrochloride Production by Manufacturers (2021-2026)
- 3.2 Global Metformin Hydrochloride Production Value by Manufacturers (2021-2026)
- 3.3 Global Metformin Hydrochloride Average Price by Manufacturers (2021-2026)
- 3.4 Global Metformin Hydrochloride Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Metformin Hydrochloride Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Metformin Hydrochloride Manufacturers, Product Type & Application
- 3.7 Global Metformin Hydrochloride Manufacturers Established Date
- 3.8 Global Metformin Hydrochloride Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Aarti Drugs
- 4.1.1 Aarti Drugs Metformin Hydrochloride Company Information
- 4.1.2 Aarti Drugs Metformin Hydrochloride Business Overview
- 4.1.3 Aarti Drugs Metformin Hydrochloride Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Aarti Drugs Product Portfolio
- 4.1.5 Aarti Drugs Recent Developments
- 4.2 Farmhispania Group
- 4.2.1 Farmhispania Group Metformin Hydrochloride Company Information
- 4.2.2 Farmhispania Group Metformin Hydrochloride Business Overview
- 4.2.3 Farmhispania Group Metformin Hydrochloride Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 Farmhispania Group Product Portfolio
- 4.2.5 Farmhispania Group Recent Developments
- 4.3 CR Double-Crane
- 4.3.1 CR Double-Crane Metformin Hydrochloride Company Information
- 4.3.2 CR Double-Crane Metformin Hydrochloride Business Overview
- 4.3.3 CR Double-Crane Metformin Hydrochloride Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 CR Double-Crane Product Portfolio
- 4.3.5 CR Double-Crane Recent Developments
- 4.4 Wanbury
- 4.4.1 Wanbury Metformin Hydrochloride Company Information
- 4.4.2 Wanbury Metformin Hydrochloride Business Overview
- 4.4.3 Wanbury Metformin Hydrochloride Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Wanbury Product Portfolio
- 4.4.5 Wanbury Recent Developments
- 4.5 Harman Finochem
- 4.5.1 Harman Finochem Metformin Hydrochloride Company Information
- 4.5.2 Harman Finochem Metformin Hydrochloride Business Overview
- 4.5.3 Harman Finochem Metformin Hydrochloride Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Harman Finochem Product Portfolio
- 4.5.5 Harman Finochem Recent Developments
- 4.6 Exemed Pharmaceuticals
- 4.6.1 Exemed Pharmaceuticals Metformin Hydrochloride Company Information
- 4.6.2 Exemed Pharmaceuticals Metformin Hydrochloride Business Overview
- 4.6.3 Exemed Pharmaceuticals Metformin Hydrochloride Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Exemed Pharmaceuticals Product Portfolio
- 4.6.5 Exemed Pharmaceuticals Recent Developments
- 4.7 USV
- 4.7.1 USV Metformin Hydrochloride Company Information
- 4.7.2 USV Metformin Hydrochloride Business Overview
- 4.7.3 USV Metformin Hydrochloride Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 USV Product Portfolio
- 4.7.5 USV Recent Developments
- 4.8 Shijiazhuang Polee Pharmaceutical
- 4.8.1 Shijiazhuang Polee Pharmaceutical Metformin Hydrochloride Company Information
- 4.8.2 Shijiazhuang Polee Pharmaceutical Metformin Hydrochloride Business Overview
- 4.8.3 Shijiazhuang Polee Pharmaceutical Metformin Hydrochloride Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 Shijiazhuang Polee Pharmaceutical Product Portfolio
- 4.8.5 Shijiazhuang Polee Pharmaceutical Recent Developments
- 4.9 Keyuan Pharmaceutical
- 4.9.1 Keyuan Pharmaceutical Metformin Hydrochloride Company Information
- 4.9.2 Keyuan Pharmaceutical Metformin Hydrochloride Business Overview
- 4.9.3 Keyuan Pharmaceutical Metformin Hydrochloride Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 Keyuan Pharmaceutical Product Portfolio
- 4.9.5 Keyuan Pharmaceutical Recent Developments
- 4.10 Shouguang Fukang Pharmaceutical
- 4.10.1 Shouguang Fukang Pharmaceutical Metformin Hydrochloride Company Information
- 4.10.2 Shouguang Fukang Pharmaceutical Metformin Hydrochloride Business Overview
- 4.10.3 Shouguang Fukang Pharmaceutical Metformin Hydrochloride Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Shouguang Fukang Pharmaceutical Product Portfolio
- 4.10.5 Shouguang Fukang Pharmaceutical Recent Developments
- 4.11 Vistin Pharma
- 4.11.1 Vistin Pharma Metformin Hydrochloride Company Information
- 4.11.2 Vistin Pharma Metformin Hydrochloride Business Overview
- 4.11.3 Vistin Pharma Metformin Hydrochloride Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 Vistin Pharma Product Portfolio
- 4.11.5 Vistin Pharma Recent Developments
5 Global Metformin Hydrochloride Production by Region
- 5.1 Global Metformin Hydrochloride Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Metformin Hydrochloride Production by Region: 2021-2032
- 5.2.1 Global Metformin Hydrochloride Production by Region: 2021-2026
- 5.2.2 Global Metformin Hydrochloride Production Forecast by Region (2027-2032)
- 5.3 Global Metformin Hydrochloride Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Metformin Hydrochloride Production Value by Region: 2021-2032
- 5.4.1 Global Metformin Hydrochloride Production Value by Region: 2021-2026
- 5.4.2 Global Metformin Hydrochloride Production Value Forecast by Region (2027-2032)
- 5.5 Global Metformin Hydrochloride Market Price Analysis by Region (2021-2026)
- 5.6 Global Metformin Hydrochloride Production and Value, YOY Growth
- 5.6.1 North America Metformin Hydrochloride Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Metformin Hydrochloride Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Metformin Hydrochloride Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Metformin Hydrochloride Production Value Estimates and Forecasts (2021-2032)
6 Global Metformin Hydrochloride Consumption by Region
- 6.1 Global Metformin Hydrochloride Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Metformin Hydrochloride Consumption by Region (2021-2032)
- 6.2.1 Global Metformin Hydrochloride Consumption by Region: 2021-2026
- 6.2.2 Global Metformin Hydrochloride Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Metformin Hydrochloride Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Metformin Hydrochloride Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Metformin Hydrochloride Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Metformin Hydrochloride Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Metformin Hydrochloride Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Metformin Hydrochloride Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Metformin Hydrochloride Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Metformin Hydrochloride Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Metformin Hydrochloride Production by Type (2021-2032)
- 7.1.1 Global Metformin Hydrochloride Production by Type (2021-2032) & (K Tons)
- 7.1.2 Global Metformin Hydrochloride Production Market Share by Type (2021-2032)
- 7.2 Global Metformin Hydrochloride Production Value by Type (2021-2032)
- 7.2.1 Global Metformin Hydrochloride Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Metformin Hydrochloride Production Value Market Share by Type (2021-2032)
- 7.3 Global Metformin Hydrochloride Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Metformin Hydrochloride Production by Application (2021-2032)
- 8.1.1 Global Metformin Hydrochloride Production by Application (2021-2032) & (K Tons)
- 8.1.2 Global Metformin Hydrochloride Production Market Share by Application (2021-2032)
- 8.2 Global Metformin Hydrochloride Production Value by Application (2021-2032)
- 8.2.1 Global Metformin Hydrochloride Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Metformin Hydrochloride Production Value Market Share by Application (2021-2032)
- 8.3 Global Metformin Hydrochloride Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Metformin Hydrochloride Value Chain Analysis
- 9.1.1 Metformin Hydrochloride Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Metformin Hydrochloride Production Mode & Process
- 9.2 Metformin Hydrochloride Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Metformin Hydrochloride Distributors
- 9.2.3 Metformin Hydrochloride Customers
10 Global Metformin Hydrochloride Analyzing Market Dynamics
- 10.1 Metformin Hydrochloride Industry Trends
- 10.2 Metformin Hydrochloride Industry Drivers
- 10.3 Metformin Hydrochloride Industry Opportunities and Challenges
- 10.4 Metformin Hydrochloride Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst